Key Insights

Highlights

Success Rate

100% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 25 trials

Success Rate

100.0%

+13.5% vs benchmark

Late-Stage Pipeline

4%

1 trials in Phase 3/4

Results Transparency

0%

0 of 7 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

19Total
Not Applicable (17)
P 1 (1)
P 3 (1)

Trial Status

Not Yet Recruiting9
Completed7
Recruiting6
Enrolling By Invitation2
Unknown1

Trial Success Rate

100.0%

Benchmark: 86.5%

Based on 7 completed trials

Clinical Trials (25)

Showing 20 of 20 trials
NCT07263022Phase 3Recruiting

Cognitive Strategies in Early Psychosis 2

NCT07647380Not ApplicableRecruitingPrimary

TIS for Improving Cognitive Impairment in Schizophrenia

NCT07703670Not ApplicableRecruitingPrimary

MicroRNAs as Biomarkers in First Episode Schizophrenia

NCT07141966CompletedPrimary

Assessment of Physical Activity, Balance, Muscle Strength, and Cognitive Function in Patients Diagnosed With Schizophrenia

NCT07658898Not ApplicableNot Yet RecruitingPrimary

dACC-Targeted Temporal Interference for Negative and Cognitive Symptoms in Schizophrenia

NCT07652866Not ApplicableNot Yet RecruitingPrimary

Mechanisms of Sulforaphane Supplementation in Alleviating Negative Symptoms and Cognitive Impairment in Schizophrenia

NCT07434479Not ApplicableRecruitingPrimary

A Virtual Reality Mindfulness Application for Aggression in Schizophrenia

NCT07315685Not ApplicableNot Yet Recruiting

Understanding and Treating Severe and Resistant Pathological Aggression: Using Deep Brain Stimulation to Treat Resistant Aggression

NCT07626034Phase 1Not Yet RecruitingPrimary

A Positron Emission Tomography (PET) Study to Evaluate Dopamine D2 and D3 Receptor Occupancy by SIPI6398

NCT07618338Not ApplicableCompletedPrimary

Virtual Reality-Based Smoking Cessation Treatment in Patients With Schizophrenia

NCT07130500Not ApplicableEnrolling By InvitationPrimary

Incentives and Long-Acting Injectable Adherence After Involuntary Hospitalization

NCT07488156Not ApplicableNot Yet RecruitingPrimary

Improving Health Literacy in Patients With Schizophrenia Spectrum Disorder

NCT07445802Not ApplicableNot Yet Recruiting

Medication Adherence in Severe Mental Illness: a Promotion Program

NCT07445620Not ApplicableNot Yet Recruiting

Comparison of Accelerated Intermittent Theta Burst Stimulation vs High Frequency Transcranial Magnetic Stimulation (Hf-rTMS) on Cognitivesymptoms in Treatment-resistant Schizophrenia

NCT07434388CompletedPrimary

LRFN5 and OLFM4 in Schizophrenia

NCT07177261Not ApplicableRecruitingPrimary

Inter-Brain Synchrony in Schizophrenia

NCT07375199Not ApplicableNot Yet RecruitingPrimary

Reducing Mental Health Stigmatization Among Healthcare Workers and Students Using a Virtual Reality Protocol: The VIRTUS Protocol

NCT07309172RecruitingPrimary

KetoBrain: Brain Energy Metabolism in Schizophrenia

NCT07234851Enrolling By InvitationPrimary

Understanding Mechanisms of Synaptic Degeneration Underlying Clinical Symptoms in Patients With MDs and NDs.

NCT07154407Not ApplicableNot Yet RecruitingPrimary

AI-assisted Masticatory Muscle Training in Patients With Schizophrenia

Scroll to load more

Research Network

Activity Timeline